Skip to main content
Clinical Trials/CTRI/2024/03/064550
CTRI/2024/03/064550Not yet recruitingPhase 2

A clinical study of Haritakyadi Churna with special reference to ??? ??? ? ????? ???? in management of Amavata. - NI

Institute of Medical Science Faculty of Ayurveda0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Clinical feature of disease according to modern and Ayurveda.
  • Fulfilling the criteria for diagnosis of rheumatoid arthritis approved by Disease activity score 28 and ACR EULAR2010.
  • Chronicity of disease not more than 3 years.
  • Patients willing to participate in the above trial and given informed consent.

Exclusion Criteria

  • Patients suffering from any other acute disease/any infectious disease /chronic disease.
  • Patients having severe deformities.
  • Severe ankylosed joints and Ankylosing Spondylitis.
  • Rheumatic Arthritis, Septic Arthritis, Osteoarthritis and Gouty Arthritis.
  • Rheumatoid Arthritis associated with other systemic disorder.

Investigators

Sponsor
Institute of Medical Science Faculty of Ayurveda

Similar Trials

To know the effect of Haritakyadi Churna... | Clinical Trial